Следене
René Cordtz
René Cordtz
Потвърден имейл адрес: rn.dk
Заглавие
Позовавания
Позовавания
Година
Incidence and severeness of COVID-19 hospitalization in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark
R Cordtz, J Lindhardsen, BG Soussi, J Vela, L Uhrenholt, R Westermann, ...
Rheumatology 60 (SI), SI59-SI67, 2021
1232021
Predictors of revision, prosthetic joint infection and mortality following total hip or total knee arthroplasty in patients with rheumatoid arthritis: a nationwide cohort study …
RL Cordtz, K Zobbe, P Højgaard, LE Kristensen, S Overgaard, A Odgaard, ...
Annals of the rheumatic diseases 77 (2), 281-288, 2018
1162018
Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project
LK Mercer, AC Regierer, X Mariette, WG Dixon, E Baecklund, K Hellgren, ...
Annals of the rheumatic diseases 76 (12), 2025-2030, 2017
942017
Gender differences in biologic treatment outcomes—a study of 1750 patients with psoriatic arthritis using Danish Health Care Registers
P Højgaard, C Ballegaard, R Cordtz, K Zobbe, M Clausen, B Glintborg, ...
Rheumatology 57 (9), 1651-1660, 2018
772018
Incidence of hip and knee replacement in patients with rheumatoid arthritis following the introduction of biological DMARDs: an interrupted time-series analysis using …
RL Cordtz, S Hawley, D Prieto-Alhambra, P Højgaard, K Zobbe, ...
Annals of the rheumatic diseases 77 (5), 684-689, 2018
692018
Incidence of hip and knee replacement in patients with rheumatoid arthritis following the introduction of biological DMARDs: an interrupted time-series analysis using …
RL Cordtz, S Hawley, D Prieto-Alhambra, P Højgaard, K Zobbe, ...
Annals of the rheumatic diseases 77 (5), 684-689, 2018
692018
Impact of comorbidities on tumor necrosis factor inhibitor therapy in psoriatic arthritis: a population‐based cohort study
C Ballegaard, P Højgaard, L Dreyer, R Cordtz, TS Jørgensen, ...
Arthritis care & research 70 (4), 592-599, 2018
692018
Methotrexate and risk of interstitial lung disease and respiratory failure in rheumatoid arthritis: a nationwide population-based study
EH Ibfelt, RK Jacobsen, TI Kopp, RL Cordtz, AS Jakobsen, N Seersholm, ...
Rheumatology 60 (1), 346-352, 2021
602021
Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the ‘JAK-pot’collaboration
K Lauper, M Iudici, D Mongin, SA Bergstra, D Choquette, C Codreanu, ...
Annals of the rheumatic diseases 81 (10), 1358-1366, 2022
542022
Risk of second malignant neoplasm and mortality in patients with rheumatoid arthritis treated with biological DMARDs: a Danish population-based cohort study
L Dreyer, RL Cordtz, IMJ Hansen, LE Kristensen, ML Hetland, ...
Annals of the Rheumatic Diseases 77 (4), 510-514, 2018
482018
Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry
L Dreyer, M Magyari, B Laursen, R Cordtz, F Sellebjerg, H Locht
Annals of the Rheumatic Diseases 75 (4), 785-786, 2016
482016
Secular trends in the incidence and prevalence of gout in Denmark from 1995 to 2015: a nationwide register-based study
K Zobbe, D Prieto-Alhambra, R Cordtz, P Højgaard, JS Hindrup, ...
Rheumatology 58 (5), 836-839, 2019
412019
Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis-A nationwide cohort study from the …
A Egeberg, NAL Rosenø, D Thein, EH Lørup, ML Nielsen, L Nymand, ...
Seminars in Arthritis and Rheumatism 53, 151979, 2022
402022
Risk of neuroinflammatory events in arthritis patients treated with tumour necrosis factor alpha inhibitors: a collaborative population-based cohort study from Denmark and Sweden
TI Kopp, B Delcoigne, EV Arkema, RK Jacobsen, M Magyari, EH Ibfelt, ...
Annals of the Rheumatic Diseases 79 (5), 566-572, 2020
382020
Incidence of COVID-19 hospitalisation in patients with systemic lupus erythematosus: a nationwide cohort study from Denmark
R Cordtz, S Kristensen, LPH Dalgaard, R Westermann, K Duch, ...
Journal of clinical medicine 10 (17), 3842, 2021
292021
Association between NICE guidance on biologic therapies with rates of hip and knee replacement among rheumatoid arthritis patients in England and Wales: an interrupted time …
S Hawley, R Cordtz, L Dreyer, CJ Edwards, NK Arden, A Delmestri, ...
Seminars in arthritis and rheumatism 47 (5), 605-610, 2018
282018
COVID-19 infection and hospitalization risk according to vaccination status and DMARD treatment in patients with rheumatoid arthritis
R Cordtz, S Kristensen, R Westermann, K Duch, F Pearce, J Lindhardsen, ...
Rheumatology 62 (1), 77-88, 2023
232023
Malignant progression of precancerous lesions of the uterine cervix following biological DMARD therapy in patients with arthritis
R Cordtz, L Mellemkjær, B Glintborg, ML Hetland, L Dreyer
Annals of the Rheumatic Diseases 74 (7), 1479-1480, 2015
222015
Risk of medical complications following total hip or knee arthroplasty in patients with rheumatoid arthritis: a register-based cohort study from Denmark
R Cordtz, A Odgaard, LE Kristensen, S Overgaard, L Dreyer
Seminars in Arthritis and Rheumatism 50 (1), 30-35, 2020
192020
Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: a Danish nationwide cohort study
R Westermann, K Zobbe, R Cordtz, JH Haugaard, L Dreyer
Lupus 30 (5), 752-761, 2021
162021
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20